Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: Clinical features and usefulness of conventional diagnostic tests

Transplant Infectious Disease

Volumn 9, Issue 3, 2007, Pages 203-210

  Fica, A ^a   Cervera, C ^a   Perez N ^a   Marcos, M A ^a   Ramirez J ^a   Linares, L ^a   Soto, G ^a   Navasa, M ^a   Cofan, F ^a   Ricart, M J ^a   Perez Villa F ^a   Pumarola, T ^a   Moreno, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cytomegalovirus; End organ disease; Immunohistochemical diagnosis; Solid organ transplantation

Indexed keywords

BASILIXIMAB; CEFAZOLIN; CEFEPIME; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS; TEICOPLANIN; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL INFECTION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART DISEASE; HEPATITIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY INFECTION; LABORATORY TEST; LEUKOPENIA; MALE; MEDICAL RECORD; ORGAN DONOR; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PANCREAS DISEASE; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PP65 ANTIGENEMIA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEROLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; AGED; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; FOSCARNET; GANCICLOVIR; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; TRANSPLANTATION; VIRAL MATRIX PROTEINS;

EID: 34547736447     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2007.00220.x     Document Type: Article

References (22)

1. Paya CV. Economic impact of cytomegalovirus in solid organ transplantation. Transpl Infect Dis 2001 3 (Suppl 2): 14 19.
2. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002 34: 1094 1097.
3. Griffiths PD, Cope AV, Hassan-Walker AF, Emery VC. Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation. Transpl Infect Dis 1999 1: 179 186.
4. Niubo J, Perez JL, Martínez-Lacasa JT, et al. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients. Diagn Microbiol Infect Dis 1996 24: 19 24.
5. Meyer-Koenig U, Weidmann M, Kirste G, Hufert FT. Cytomegalovirus infection in organ-transplant recipients: diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and quantitative Taqman PCR. Transplantation 2004 77: 1692 1698.
6. Seehofer D, Meisel H, Reyes N, et al. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transplant 2004 4: 1331 1337.
7. Piiparinen H, Höckerstedt K, Grönhagen-Riska C, Lautenschlager I. Comparison of two quantitaive CMV PCR test, Cobas Amplicor CMV monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004 30: 258 266.
8. Pinchoff RJ, Kaufman SS, Magid MS, et al. Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation 2003 76: 183 189.
9. Itoh T, Takahashi T, Kusaka K, et al. Herpes simplex esophagitis from 1307 autopsy cases. J Gastroenterol Hepatol 2003 18: 1407 1411.
10. Muir SW, Murray J, Farquharson MA, Wheatley DJ, McPhaden AR. Detection of cytomegalovirus in upper gastrointestinal biopsies from heart transplant recipients: comparison of light microscopy, immunocytochemistry, in situ hybridisation, and nested PCR. J Clin Pathol 1998 51: 807 811.
11. Limaye AP, Bakthavatsalam R, Kim HW, et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 2004 78: 1390.
12. Razonable RR, Rivero A, Rodriguez A, et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001 184: 1461.
13. Limaye AP, Bakthavatsalam R, Kim HW, et al. Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis. Transplantation 2006 81: 1645 1652.
14. Singh N. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis 2005 40: 704 708.
15. Stratta RJ. Clinical patterns and treatment of cytomegalovirus infection after solid-organ transplantation. Transplant Proc 1993 25 (Suppl 4): 15 21.
16. Esforzado N, Poch E, Almirall J, Bombi JA, Lopez-Pedret J, Revert L. Cytomegalovirus colitis in chronic renal failure. Clin Neprol 1993 39: 275 278.
17. Shibolet O, Ilan Y, Kalish Y, et al. Late cytomegalovirus disease following liver transplantation. Transpl Int 2003 16: 861 865.
18. Chetty R, Roskell DE. Cytomegalovirus infection in the gastrointestinal tract. J Clin Pathol 1994 47: 968 972.
19. Page MJ, Dreese JC, Poritz LS, Koltun WA. Cytomegalovirus enteritis: a highly lethal condition requiring early detection and intervention. Dis Colon Rectum 1998 41: 619 623.
20. Kulkarni A, Westmoreland D, Fox JD. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients. Clin Microbiol Infect 2001 7: 179 186.
21. Skiest DJ, Crosby C. CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era. J Clin Virol 2003 28: 203 213.
22. Humar A, Paya C, Pescovitz MD, et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients. Am J Transplant 2004 4: 644 649.